Evommune Inc (EVMN)

Finanzdaten der Evommune Inc-Aktie (EVMN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	10.00
	45.68%34.90	23.95	29.72	23.33
Research and Development	52.50%26.41	17.32	20.40	19.64
Depreciation and Amortization	58.17%0.55	0.35	0.33	-
Operating Income/Loss	45.68%-34.90	-23.95	-29.72	-13.33
Income Tax Expense/Benefit	-	-	-	-
	48.78%-32.25	-21.67	-28.27	-12.48
Attributable To Parent	48.78%-32.25	-21.67	-28.27	-12.48
Basic Average Shares	7.32%36.14	33.67	-	1.55
Diluted Average Shares	7.32%36.14	33.67	-	1.55
Basic Earnings Per Share	39.06%-0.89	-0.64	-	-8.07
Diluted Earnings Per Share	39.06%-0.89	-0.64	-	-8.07